These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 20797455)

  • 1. Enterovirus 71 virus-like particle vaccine: improved production conditions for enhanced yield.
    Chung CY; Chen CY; Lin SY; Chung YC; Chiu HY; Chi WK; Lin YL; Chiang BL; Chen WJ; Hu YC
    Vaccine; 2010 Oct; 28(43):6951-7. PubMed ID: 20797455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced enterovirus 71 virus-like particle yield from a new baculovirus design.
    Lin SY; Yeh CT; Li WH; Yu CP; Lin WC; Yang JY; Wu HL; Hu YC
    Biotechnol Bioeng; 2015 Oct; 112(10):2005-15. PubMed ID: 25997678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of EV71 virus-like particle purification processes.
    Lin SY; Chiu HY; Chiang BL; Hu YC
    Vaccine; 2015 Nov; 33(44):5966-73. PubMed ID: 25939279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient expression of enterovirus 71 based on virus-like particles vaccine.
    Kim HJ; Son HS; Lee SW; Yoon Y; Hyeon JY; Chung GT; Lee JW; Yoo JS
    PLoS One; 2019; 14(3):e0210477. PubMed ID: 30845175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges.
    Yan Q; Wu L; Chen L; Qin Y; Pan Z; Chen M
    Vaccine; 2016 Jul; 34(35):4196-4204. PubMed ID: 27373596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression, purification and characterization of enterovirus-71 virus-like particles.
    Chung YC; Huang JH; Lai CW; Sheng HC; Shih SR; Ho MS; Hu YC
    World J Gastroenterol; 2006 Feb; 12(6):921-7. PubMed ID: 16521221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-yield production of recombinant virus-like particles of enterovirus 71 in Pichia pastoris and their protective efficacy against oral viral challenge in mice.
    Zhang C; Ku Z; Liu Q; Wang X; Chen T; Ye X; Li D; Jin X; Huang Z
    Vaccine; 2015 May; 33(20):2335-41. PubMed ID: 25820068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells.
    Somasundaram B; Chang C; Fan YY; Lim PY; Cardosa J; Lua L
    Methods; 2016 Feb; 95():38-45. PubMed ID: 26410190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The assemblage, purification and characterization of EV71 VLPs expressed in baculovirus].
    Cao L; Yi Y; Song JD; Tian MM; Tian RG; Meng QL; Qiu F; Jia ZY; Bi SL
    Bing Du Xue Bao; 2012 May; 28(3):201-6. PubMed ID: 22764520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enterovirus71 virus-like particles produced from insect cells and purified by multistep chromatography elicit strong humoral immune responses in mice.
    Zhao D; Sun B; Jiang H; Sun S; Kong FT; Ma Y; Jiang L; Bai L; Chen X; Yang P; Liu C; Xu Y; Su W; Kong W; Xu F; Jiang C
    J Appl Microbiol; 2015 Oct; 119(4):1196-205. PubMed ID: 26248815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice.
    Li HY; Han JF; Qin CF; Chen R
    Vaccine; 2013 Jul; 31(32):3281-7. PubMed ID: 23726823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge.
    Liu Q; Yan K; Feng Y; Huang X; Ku Z; Cai Y; Liu F; Shi J; Huang Z
    Vaccine; 2012 Oct; 30(47):6642-8. PubMed ID: 22959985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chimeric enterovirus 71 virus-like particle displaying conserved coxsackievirus A16 epitopes elicits potent immune responses and protects mice against lethal EV71 and CA16 infection.
    Luo J; Huo C; Qin H; Hu J; Lei L; Pan Z
    Vaccine; 2021 Jul; 39(30):4135-4143. PubMed ID: 34116877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge.
    Chung YC; Ho MS; Wu JC; Chen WJ; Huang JH; Chou ST; Hu YC
    Vaccine; 2008 Mar; 26(15):1855-62. PubMed ID: 18329759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninfectious virus-like particle antigen for detection of swine vesicular disease virus antibodies in pigs by enzyme-linked immunosorbent assay.
    Ko YJ; Choi KS; Nah JJ; Paton DJ; Oem JK; Wilsden G; Kang SY; Jo NI; Lee JH; Kim JH; Lee HW; Park JM
    Clin Diagn Lab Immunol; 2005 Aug; 12(8):922-9. PubMed ID: 16085909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A bivalent virus-like particle based vaccine induces a balanced antibody response against both enterovirus 71 and norovirus in mice.
    Wang X; Ku Z; Dai W; Chen T; Ye X; Zhang C; Zhang Y; Liu Q; Jin X; Huang Z
    Vaccine; 2015 Oct; 33(43):5779-5785. PubMed ID: 26424606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Virus-like particle-based vaccine against coxsackievirus A6 protects mice against lethal infections.
    Shen C; Ku Z; Zhou Y; Li D; Wang L; Lan K; Liu Q; Huang Z
    Vaccine; 2016 Jul; 34(34):4025-31. PubMed ID: 27340093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ebola virus-like particles produced in insect cells exhibit dendritic cell stimulating activity and induce neutralizing antibodies.
    Ye L; Lin J; Sun Y; Bennouna S; Lo M; Wu Q; Bu Z; Pulendran B; Compans RW; Yang C
    Virology; 2006 Aug; 351(2):260-70. PubMed ID: 16678231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin.
    Bright RA; Carter DM; Daniluk S; Toapanta FR; Ahmad A; Gavrilov V; Massare M; Pushko P; Mytle N; Rowe T; Smith G; Ross TM
    Vaccine; 2007 May; 25(19):3871-8. PubMed ID: 17337102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and characterization of an enterovirus 71 (EV71) virus-like particles (VLPs) vaccine produced in
    Yang Z; Gao F; Wang X; Shi L; Zhou Z; Jiang Y; Ma X; Zhang C; Zhou C; Zeng X; Liu G; Fan J; Mao Q; Shi L
    Hum Vaccin Immunother; 2020 Jul; 16(7):1602-1610. PubMed ID: 31403352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.